Quick Read
Acute cholangitis is not simply “infection near the liver”. It is infection of an obstructed biliary system, so antibiotics treat the microbial component while drainage or removal of the obstruction may be required to achieve source control.
The distinct Medicine Web job is: fever/jaundice/right-upper-quadrant pain or septic deterioration → biochemical and imaging evidence of biliary obstruction/inflammation → severity grading → early antimicrobial treatment → identify stone, stricture, tumour or stent/device cause → urgent or early biliary drainage according to severity → organ-support receipt → definitive treatment of the underlying obstruction → recurrence prevention.
Wait, What? Antibiotics Can Be Correct and Still Be Incomplete
The Tokyo Guidelines 2018 explicitly combine antimicrobial treatment with biliary drainage when obstruction and severity warrant it. In a closed, infected biliary system, source control can be as important as the antibiotic choice.
Anti-collapse rules: jaundice ≠ cholangitis; gallstone ≠ cholangitis automatically; fever absent ≠ infection excluded; antibiotics started ≠ obstruction relieved; ERCP completed ≠ source permanently eliminated; bilirubin falling ≠ sepsis fully resolved.
The Cholangitis Tube
Clinical signal → liver tests/inflammation → ultrasound/CT/MRCP or other imaging → obstruction + infection probability → severity grade → antibiotics + resuscitation → ERCP or alternate drainage if indicated → bile-flow and organ-function receipt → remove stone/replace stent/treat stricture or tumour → follow-up and recurrence prevention.
1. The Owner Is Infected Obstructed Bile Flow
The Gastrointestinal & Liver Medicine Web owns hepatobiliary disease broadly. The Advanced Interventional Endoscopy Web owns ERCP procedure mechanics. This node owns the emergency trajectory where infected bile cannot drain adequately.
2. Diagnosis Needs Infection + Cholestasis + Imaging Context
The Tokyo Guidelines structure diagnosis around systemic inflammation, cholestatic evidence and imaging findings. That is more reliable than expecting the classic Charcot triad to be present in every patient.
3. Severity Determines Urgency
Organ dysfunction, haemodynamic instability and other severity features change the timing and setting of drainage. Severe cholangitis can become septic shock and requires rapid escalation.
4. Imaging Answers the Plumbing Question
Ultrasound, CT, MRCP and endoscopic imaging can identify duct dilatation, stones, strictures, stents or masses. Imaging does not replace microbiology, and microbiology does not reveal anatomy.
5. Antibiotics Treat the Infection Component
Antimicrobial choice depends on severity, community versus healthcare exposure, prior procedures, local resistance patterns and organ function. Treatment should narrow when cultures and response permit.
6. ERCP Can Provide Source Control
Endoscopic biliary drainage can decompress the system, remove selected stones and place or exchange stents. The crucial receipt is not merely “ERCP performed” but bile draining + obstruction addressed + physiology improving.
7. When ERCP Is Not Possible, Ownership Can Move
Percutaneous transhepatic drainage or surgical approaches may be required when endoscopic access fails or anatomy prevents it. Interventional Radiology or Surgery then owns the procedural route.
8. A Stent Can Become Part of the Cause
Previously placed biliary stents can occlude or become colonised. Device history therefore belongs in the acute record.
9. Gallstone Cholangitis Needs Definitive Stone Prevention
Clearing the duct treats the emergency, but gallbladder stones can remain a recurrent source. Cholecystectomy or other definitive management may be needed depending on the patient and anatomy.
10. Malignant Obstruction Has a Different Long-Term Owner
Pancreatic, biliary or other malignancy can obstruct bile flow. Oncology, Hepatobiliary Surgery or Palliative Care may become the long-term owner even after the acute infection is controlled.
11. Sepsis Is the Organ-Failure Destination
If infection produces organ dysfunction, the Sepsis & Septic Shock Web owns the systemic failure state while cholangitis remains the source.
12. Evidence, Uncertainty and Correction
The correction loop is suspected biliary infection → severity + anatomy → antibiotics/resuscitation → drainage/source control → organ/liver-test receipt → refine cause → definitive obstruction prevention.
13. RFE: Did We Treat Both the Infection and the Blocked System That Sustained It?
The Medicine RFE asks whether timely, evidence-grounded and ethically authorised help reaches the human and improves outcomes without preventable harm. In acute cholangitis, success means sepsis was recognised early, antimicrobial treatment began promptly, biliary drainage occurred when indicated, organ function recovered and the underlying obstructive cause was not left waiting for the next infection.
eduKateAI Acute Cholangitis Tube Card
- TRIGGER: fever, jaundice, RUQ pain or unexplained sepsis?
- INFLAMMATION: WBC/CRP and cultures?
- CHOLESTASIS: bilirubin/ALP/GGT trajectory?
- ANATOMY: stone, stricture, stent, tumour or uncertain?
- SEVERITY: organ dysfunction and Tokyo grade?
- ANTIBIOTIC: empirical start and later narrowing?
- DRAINAGE: ERCP, percutaneous, surgical or not required?
- RECEIPT: pressure, fever, bilirubin and organ recovery?
- RETURN: definitive stone/stricture/stent/tumour management?
Canonical External Source
Tokyo Guidelines 2018 — Acute Cholangitis and Cholecystitis
Educational boundary: Acute cholangitis can progress rapidly to sepsis. This page explains information architecture and does not determine antibiotic regimens, drainage timing or ERCP eligibility for an individual.